14
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Circadian and Diurnal Variation of Circulating Immune Complexes, Complement-mediated Solubilization, and the Complement Split Product C3d in Rheumatoid Arthritis

, , , , &
Pages 113-118 | Published online: 12 Jul 2009

References

  • Baatrup G., Petersen I., Jensenius J. C., Svehag S.-E. Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera. Clin Exp Immunol 1983; 54: 439
  • Baatrup G., Petersen I., Svehag S.-E., Brandslund I. A standardized method for quantitating the complement-mediated immune complex solubilizing capacity of human serum. J Immunol Meth 1983; 59: 369
  • Baatrup G., Petersen I., Svehag S.-E., Jepsen H. H., Brandslund I. Solubilization of immune complexes in complement factor deficient sera and the influence of temperature, ionic strength and divalent cations on the solubilization reaction. J Clin Lab Immunol 1984; 14: 185
  • Brandslund I., Siersted H. C., Jensenius J. C., Svehag S.-E. Detection and quantitation of immune complexes with a rapid polyethylene glycol precipitation complement consumption method (PEG-CC). Methods in Enzymology, J. J. Langone, H. van Vunakis. Academic Press, New York 1981; 551, col. 74, part C
  • Brandslund J., Siersted H. C., Svehag S.-E., Teisner B. Double-decker rocket immunoelectrophoresis for direct quantitation of complement C3 split products with C3d specificities in plasma. J Immunol Meth 1981; 44: 63
  • Cove-Smith J. R., Kabler P., Pownall R., Knapp M. S. Circadian variation in an immune response in man. Br Med J 1978; 978: 253
  • Czop J., Nussenzweig V. Studies on the mechanism of solubilization of immune precipitates by complement. J Exp Med 1976; 143: 615
  • Dayer E., Gerster J. C., Aguado M. T., Lambert P. H. Capacity to solubilize immune complexes in sera and synovial fluids from patients with rheumatoid arthritis. Arthritis and Rheumatism 1983; 26: 156
  • Fleming A., Charlesworth J., Liew M., Portek I., Bertouch J., Quin J. Clinical significance of immune complexes in rheumatoid disease. Aust NZ J Med 1981; 11: 231
  • Harkness J. A. L., Richter M. B., Panayi G. S., Van de Pette K., Unger A., Pownall R., Geddawi M. Circadian variation in disease activity in rheumatoid arthritis. Br Med J 1982; 284: 551
  • Kowanko I. C., Pownall R., Knapp M. S., Swannell A. J., Mahoney P. G. C. Circadian variations in the signs and symptoms of rheumatoid arthritis and in the therapeutic effectiveness of flurbiprofen at different times of day. Br J Clin Pharmacol 1981; 11: 477
  • Miller G. W., Nussenzweig V. A new complement function: solubilization of antigen-antibody aggregates
  • Michell W. S., Naama J. K., Veitch J., Whaley K. IgM-RF prevents complement-mediated inhibition of immune precipitation. Immunology 1984; 54: 445
  • Nydegger U. E., Zubler R. H., Gabay R., Joliat G., Karagevrekis C., Lambert P. H., Mischer P. A. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes and clinical activity. J Clin Invest 1977; 59: 862
  • Packard B. D., Weiler J. M. Steroids inhibit activation of the alternative amplification pathway of complement. Infect Immun 1983; 40: 101
  • Ritchie D. M., Boyle J. A., McInnes J. M., Jasani M. K., Kalakos T. G., Grieveson P., Buchanan W. W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Quarterly Journal of Medicine, New Series XXXVII 1968; 147: 393
  • Svehag S.-E., Baatrup G., Petersen I. Characterization of circulating immune complexes and their solubilization by complement. Recent Developments in Clinical Immunology, W. G. Reeves. Elsevier Science Publishers B. V., Amsterdam 1984; 111–34
  • Teisner B., Brandslund I., Grunnet N., Hansen L. K., Thellesen J., Svehag S.-E. Acute complement activation during an anaphylactoid reaction to blood transfusion and the disappearance rate of C3c and C3d from the circulation. J Clin Lab Immunol 1983; 13: 63

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.